Clinical caution with social media; Health problems versus coverage; MD new Rx adoption (PMRV–3/17/2014)

News on this week’s Pharma Research VIDEO Report:
1) The Tufts Center for the Study of Drug Development comments on the pharmaceutical industry’s cautious use of social media, explaining how it could be accelerated.
2) Prosper Insights & Analytics released its “Healthcare Coverage Vital Signs Matrix,” which studies the links between health problems of individuals and their actual healthcare coverage.
3) M/A/R/C Research EVP Randy Wahl discusses research’s tendency to overstate adoption of new drugs and what is being done about it.
4) The Center for Medicare & Medicare Services withdrew its proposal to revise Medicare Part D following protests in Washington by insurers, pharmacies, pharmacies, health providers and patients.

Med cost up 3-5%; pharmacos cut MD speaker fees; FDA eases adverse event reporting (PRVR–3/10/14)

This week’s Pharma Research VIDEO Report: 1) Costs for medications will rise 3-5% this year, after having dramatically slowed in recent years. 2) Pharmaceutical companies have radically reduced what they pay doctors to speak, well at least many of them have. 3) Generic drug manufacturers will fight FDA proposals that they be required to update their product labels when new information with concerns about branded equivalents appear. 4) FDA will make availability of adverse event reports much easier to find and collect. 5) Health care providers say the Affordable Care Act needs changes and revisions, but overwhelmingly see it as a positive step for U.S. healthcare. 6) The multimillion dollar injectable drug market for chronic conditions like diabetes may be in or a shakeup if Mir Imran’s “Robotic Pill” gets FDA approval. It is in preclinical testing. 7) Media technology company Sticky wins the PM360 award for most innovative company. 8) A press release last week declared the first broadcast medical marijuana commercial. The release pointed to Comcast as the broadcaster. Since the taping of this video, PRVR has learned that this release was part of a misleading campaign. We apologize for this mistaken report.

Here is the link to the commercial:
https://www.marijuanadoctors.com/content/page/view/91